Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Se-Il Go

Showing results (21-30 of 76) with videos related to

Pageof 8
Sort By:
Translational Lung Cancer Research|September 12, 2024
Redefining YAP1 in small cell lung cancer: shifting from a dominant subtype marker to a favorable prognostic indicatorSe-Il Go, Jung Wook Yang, Eun Jeong Jeong, et al.
World Journal of Clinical Cases|September 21, 2023
T/myeloid mixed-phenotype acute leukemia treated with venetoclax and decitabine: A case reportSungwoo Park, Eun Jeong Jeong, Jung Hun Kang, et al.
Cancer Biomarkers : Section a of Disease Markers|September 19, 2022
Endothelial activation and stress index (EASIX) as a predictive biomarker in small cell lung cancerSe-Il Go, Sungwoo Park, Myoung Hee Kang, et al.
American Journal of Clinical Oncology|January 1, 2010
A phase II study of irinotecan, continuous 5-fluorouracil, and leucovorin (FOLFIRI) combination chemotherapy for patients with recurrent or metastatic gastric cancer previously treated with a fluoropyrimidine-based regimenSeok Hyun Kim, Gyeong-Won Lee, Se Il Go, et al.
International Journal of Hematology|July 24, 2013
Nilotinib-induced interstitial lung diseaseSe-Il Go, Won Sup Lee, Gyeong-Won Lee, et al.
Cancer Epidemiology|July 14, 2026
High prevalence of non-receipt of cancer-directed therapy among the oldest old persists independent of healthcare accessibility: A population-based analysis of 82,864 patientsSe-Il Go, Rock Bum Kim, Mi-Ji Kim, et al.
Journal of Pain and Symptom Management|November 25, 2015
Gender Differences in Hiccup Patients: Analysis of Published Case Reports and Case-Control StudiesGyeong-Won Lee, Rock Bum Kim, Se Il Go, et al.
International Journal of Molecular Sciences|June 2, 2021
Activated ERK Signaling Is One of the Major Hub Signals Related to the Acquisition of Radiotherapy-Resistant MDA-MB-231 Breast Cancer CellsAnjugam Paramanantham, Eun Joo Jung, Se-Il Go, et al.
Journal of Cachexia, Sarcopenia and Muscle|October 22, 2021
Cachexia index as a potential biomarker for cancer cachexia and a prognostic indicator in diffuse large B-cell lymphomaSe-Il Go, Mi Jung Park, Sungwoo Park, et al.
Cancers|April 23, 2022
Modified FOLFIRINOX as a Second-Line Treatment for Patients with Gemcitabine-Failed Advanced Biliary Tract Cancer: A Prospective Multicenter Phase II StudyYong-Pyo Lee, Sung Yong Oh, Kwang Min Kim, et al.
Pageof 8

Showing results (21-30 of 76) with videos related to

Sort By:
Pageof 8
Translational Lung Cancer Research|September 12, 2024
Redefining YAP1 in small cell lung cancer: shifting from a dominant subtype marker to a favorable prognostic indicatorSe-Il Go, Jung Wook Yang, Eun Jeong Jeong, et al.
World Journal of Clinical Cases|September 21, 2023
T/myeloid mixed-phenotype acute leukemia treated with venetoclax and decitabine: A case reportSungwoo Park, Eun Jeong Jeong, Jung Hun Kang, et al.
Cancer Biomarkers : Section a of Disease Markers|September 19, 2022
Endothelial activation and stress index (EASIX) as a predictive biomarker in small cell lung cancerSe-Il Go, Sungwoo Park, Myoung Hee Kang, et al.
American Journal of Clinical Oncology|January 1, 2010
A phase II study of irinotecan, continuous 5-fluorouracil, and leucovorin (FOLFIRI) combination chemotherapy for patients with recurrent or metastatic gastric cancer previously treated with a fluoropyrimidine-based regimenSeok Hyun Kim, Gyeong-Won Lee, Se Il Go, et al.
International Journal of Hematology|July 24, 2013
Nilotinib-induced interstitial lung diseaseSe-Il Go, Won Sup Lee, Gyeong-Won Lee, et al.
Cancer Epidemiology|July 14, 2026
High prevalence of non-receipt of cancer-directed therapy among the oldest old persists independent of healthcare accessibility: A population-based analysis of 82,864 patientsSe-Il Go, Rock Bum Kim, Mi-Ji Kim, et al.
Journal of Pain and Symptom Management|November 25, 2015
Gender Differences in Hiccup Patients: Analysis of Published Case Reports and Case-Control StudiesGyeong-Won Lee, Rock Bum Kim, Se Il Go, et al.
International Journal of Molecular Sciences|June 2, 2021
Activated ERK Signaling Is One of the Major Hub Signals Related to the Acquisition of Radiotherapy-Resistant MDA-MB-231 Breast Cancer CellsAnjugam Paramanantham, Eun Joo Jung, Se-Il Go, et al.
Journal of Cachexia, Sarcopenia and Muscle|October 22, 2021
Cachexia index as a potential biomarker for cancer cachexia and a prognostic indicator in diffuse large B-cell lymphomaSe-Il Go, Mi Jung Park, Sungwoo Park, et al.
Cancers|April 23, 2022
Modified FOLFIRINOX as a Second-Line Treatment for Patients with Gemcitabine-Failed Advanced Biliary Tract Cancer: A Prospective Multicenter Phase II StudyYong-Pyo Lee, Sung Yong Oh, Kwang Min Kim, et al.
Pageof 8